|Bid||3.0000 x 800|
|Ask||3.8200 x 2900|
|Day's Range||3.1301 - 3.3499|
|52 Week Range||1.6900 - 13.5200|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 15, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.00|
Subscribe to Yahoo Finance Plus to view Fair Value for LUCD
NEW YORK, August 15, 2022--Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results
A look at the shareholders of Lucid Diagnostics Inc. ( NASDAQ:LUCD ) can tell us which group is most powerful...
NEW YORK, August 11, 2022--Lucid Diagnostics Inc. announced its subsidiary, LucidDx Labs Inc., launched four new Lucid Test Centers in California, Texas Florida and Ohio.